Neonatal long QT syndrome due to a de novo dominant negative hERG mutation

American Journal of Critical Care

Volumn 16, Issue 4, 2007, Pages

  Beery, Theresa A ^a   Shooner, Kerry A ^a   Benson, D Woodrow ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Cardiovascular Genetics

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54249137669     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88(2):782-784.
2. Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000;102(10):1178-1185.
3. Khan IA. Long QT syndrome: diagnosis and management. Am Heart J. 2002;143(1):7-14.
4. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89-95.
5. + channel exhibiting novel molecular mechanisms of long QT syndrome. FEBS Lett. 1998;423(1):5-9.
6. Wedekind H, Smits JP, Schulze-Bahr E, et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation. 2001;104(10):1158-1164.
7. Yamagishi H, Furutani M, Kamisago M, et al. A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT syndrome. Mutations in brief no. 140. Online. Hum Mutat. 1998;11(6):481. doi:10.1002/(SICI)1098-1004(1998)11:6〈481::AID-HUMU12〉3.0.CO;2-Q.
8. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99(4):529-533.
9. Yoshida H, Horie M, Otani H, Kawashima T, Onishi Y, Sasayama S. Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG. Am J Med Genet. 2001;98(4):348-352.
10. Chang CC, Acharfi S, Wu MH, et al. A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia. Cardiovasc Res. 2004;64(2):268-278.
11. Lupoglazoff JM, Denjoy I, Villain E, et al. Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations. J Am Coll Cardiol. 2004;43(5):826-830.
12. Johnson WH Jr, Yang P, Yang T, et al. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res. 2003;53(5):744-748.
13. Hofbeck M, Ulmer H, Beinder E, Sieber E, Singer H. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart. 1997;77(3):198-204.
14. Beinder E, Grancay T, Menendez T, Singer H, Hofbeck M. Fetal sinus bradycardia and the long QT syndrome. Am J Obstet Gynecol. 2001;185(3):743-747.
15. Anderson CL, Delisle BP, Anson BD, et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 2006;113(3):365-373.
16. Ficker E, Thomas D, Viswanathan PC, et al. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am J Physiol Heart Circ Physiol. 2000;279(4):H1748-H1756.
17. 609→ Gly in KCNH2 associated with severe long QT syndrome. Clin Sci (Lond). 2005;108(2):143-150.
18. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC. Compound mutations: a common cause of severe long-QT syndrome. Circulation. 2004;109(15):1834-1841.
19. Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med. 2000;343(4):262-267.
20. Schwartz PJ, Priori SG, Bloise R, et al. Molecular diagnosis in a child with sudden infant death syndrome. Lancet. 2001;358(9290):1342-1343.
21. Schwartz PJ, Montemerlo M, Facchini M, et al. The QT interval throughout the first 6 months of life: a prospective study. Circulation. 1982;66(3):496-501.
22. Napolitano NM, Rohlfs EM, Heim RA. Simultaneous detection of multiple point mutations using allele-specific oligonucleotides. In: Haines JL, ed. Current Protocols in Human Genetics. New York, NY: John Wiley & Sons Inc; 2005:9.4.1-9.4.10.
23. Kagan A, Yu Z, Fishman GI, McDonald TV. The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J Biol Chem. 2000;275(15):11241-11248.
24. Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia [published correction appears in Proc Natl Acad Sci U S A. 1996;93(16):8796]. Proc Natl Acad Sci U S A. 1996;93(5):2208-2212.
25. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807-2816.
26. Sudden Arrhythmia Death Syndromes (SADS) Foundation. An overview of the long QT syndrome, sample materials and SADS volunteer information. http://www.sads.org/LQTS.html. Accessed April 26, 2006.
27. Delisle BP, Slind JK, Kilby JA, et al. Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome. Mol Pharmacol. 2005;68(1):233-240.
28. + channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant. Circ Res. 2000;86(5):507-513.
29. Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M. Short QT syndrome. Cardiovasc Res. 2005;67(3):357-366.
30. Ficker E, Dennis AT, Obejero-Paz CA, Castaldo P, Taglialatela M, Brown AM. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. J Mol Cell Cardiol. 2000;32(12):2327-2337.